Hypopigmentation Disorder Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Feb 2019| TMR1316A| Transparency

Report Highlights

Global Hypopigmentation Disorder Treatment Market: Overview

This report analyzes the current and future scenario of the global hypopigmentation disorder treatment market. Increase in patient population with hypopigmentation disorders, growth of the pharmaceutical industry, improvement in health care infrastructure, and increase in the number of clinical trials are projected to be the major drivers of the global market during the forecast period.

The global hypopigmentation disorder treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global hypopigmentation disorder treatment market.

Global Hypopigmentation Disorder Treatment Market: Key Segments

Based on treatment, the global hypopigmentation disorder treatment market has been segmented into topical drugs, laser therapy, chemical peels, microdermabrasion, and others (phototherapy, etc.). The segments have been analyzed based on available drug products used in the treatment of hypopigmentation disorders, cost-effectiveness, and preference for industries. In terms of diseases indication, the market has been classified into vitiligo, albinism, and others. Based on end-user, the global hypopigmentation disorder treatment market has been classified into hospitals, aesthetic clinics & dermatology centers, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Hypopigmentation Disorder Treatment Market: Regional Outlook

In terms of region, the global hypopigmentation disorder treatment market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global hypopigmentation disorder treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Allergan, SkinCeuticals, Pierre Fabre, Episciences, Inc., RXi Pharmaceuticals Corporation, Obagi Cosmeceuticals LLC (Obagi Medical), and Alvogen.

The global hypopigmentation disorder treatment market has been segmented as below:

Global Hypopigmentation Disorder Treatment Market, by Treatment
Topical Drugs
Laser
Chemical Peels
Microdermabrasion
Others (phototherapy, etc.)

Global Hypopigmentation Disorder Treatment Market, by Disease Indication
Vitiligo
Albinism
Others

Global Hypopigmentation Disorder Treatment Market, by End-user
Hospitals
Aesthetic Clinics & Dermatology Centers
Others

Global Hypopigmentation Disorder Treatment Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Global Hypopigmentation Disorders Treatment Market: Pipeline Analysis
  • Table 2 : Global Hypopigmentation Disorders Treatment Market: Pipeline Analysis
  • Table 3 : Global Hypopigmentation Disorders Treatment Market: Pipeline Analysis
  • Table 4 : Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 5 : Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 6 : Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 7 : Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
  • Table 8 : North America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
  • Table 9 : North America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 10 : North America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 11 : North America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 12 : Europe Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 13 : Europe Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 14 : Europe Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 15 : Europe Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 16 : Asia Pacific Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 17 : Asia Pacific Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 18 : Asia Pacific Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 19 : Asia Pacific Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 20 : Latin America Hypopigmentation Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 21 : Latin America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 22 : Latin America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 23 : Latin America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 24 : Middle East & Africa Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 25 : Middle East & Africa Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 26 : Middle East & Africa Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
  • Table 27 : Middle East & Africa Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Figure 1 : Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 2 : Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 3 : Global Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2017
  • Figure 4 : Global Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017
  • Figure 5 : Global Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2017
  • Figure 6 : Global Hypopigmentation Disorders Treatment Market Value Share, by Region, 2017
  • Figure 7 : Global Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2018 and 2026
  • Figure 8 : Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical Drugs, 2016–2026
  • Figure 9 : Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laser Therapy, 2016–2026
  • Figure 10 : Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Peels, 2016–2026
  • Figure 11 : Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microdermabrasion, 2016–2026
  • Figure 12 : Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 13 : Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment, 2018–2026
  • Figure 14 : Global Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2018 and 2026
  • Figure 15 : Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitiligo, 2016–2026
  • Figure 16 : Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Albinism, 2016–2026
  • Figure 17 : Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 18 : Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Disease Indication, 2018–2026
  • Figure 19 : Global Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2018 and 2026
  • Figure 20 : Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2016–2026
  • Figure 21 : Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aesthetic Clinics & Dermatology Centers, 2016–2026
  • Figure 22 : Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 23 : Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by End-user, 2018–2026
  • Figure 24 : Global Hypopigmentation Disorders Treatment Market Value Share, by Region, 2018 and 2026
  • Figure 25 : Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Region, 2018–2026
  • Figure 26 : North America Hypopigmentation Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 27 : North America Hypopigmentation Disorders Treatment Market Value Share, by Country, 2018 and 2026
  • Figure 28 : North America Hypopigmentation Disorders Treatment Market Attractiveness, by Country, 2018–2026
  • Figure 29 : North America Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 30 : North America Hypopigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
  • Figure 31 : North America Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 32 : North America Hypopigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 33 : North America Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 34 : North America Hypopigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 35 : Europe Hypopigmentation Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 36 : Europe Hypopigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 37 : Europe Hypopigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 38 : Europe Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 39 : Europe Hypopigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
  • Figure 40 : Europe Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2018 and 2026
  • Figure 41 : Europe Hypopigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 42 : Europe Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 43 : Europe Hypopigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 44 : Asia Pacific Hypopigmentation Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 45 : Asia Pacific Hypopigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 46 : Asia Pacific Hypopigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 47 : Asia Pacific Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 48 : Asia Pacific Hypopigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
  • Figure 49 : Asia Pacific Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 50 : Asia Pacific Hypopigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 51 : Asia Pacific Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 52 : Asia Pacific Hypopigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 53 : Latin America Hypopigmentation Disorders Treatment Market value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 54 : Latin America Hypopigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 55 : Latin America Hypopigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 56 : Latin America Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 57 : Latin America Hypopigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
  • Figure 58 : Latin America Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2018 and 2026
  • Figure 59 : Latin America Hypopigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 60 : Latin America Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2018 and 2026
  • Figure 61 : Latin America Hypopigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 62 : Middle East & Africa Hypopigmentation Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 63 : Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2018 and 2026
  • Figure 64 : Middle East & Africa Hypopigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 65 : Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2018 and 2026
  • Figure 66 : Middle East & Africa Hypopigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
  • Figure 67 : Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2018 and 2026
  • Figure 68 : Middle East & Africa Hypopigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
  • Figure 69 : Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2018 and 2026
  • Figure 70 : Middle East & Africa Hypopigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
  • Figure 71 : Allergan Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
  • Figure 72 : Allergan R&D and Selling, General & Administrative Expenses (US$ Mn), 2016–2017
  • Figure 73 : Allergan Breakdown of Net Sales (% Share), by Business Segment, 2017
  • Figure 74 : Allergan Breakdown of Net Sales (% Share), by U.S. Specialized Therapeutics Segment, 2017
  • Figure 75 : Pierre Fabre Breakdown of Employees (% Share), by Region, 2016
  • Figure 76 : Pierre Fabre Breakdown of Net Sales (% Share), by Business Segment, 2017
  • Figure 77 : Pierre Fabre Breakdown of Net Sales of Pharmaceuticals Division (% Share), by Region, 2016
  • Figure 78 : Pierre Fabre Breakdown of Net Sales of Dermo-Cosmetics Division (% Share), by Region, 2016

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us